Nextrials Adds Multiple Customers and Initiates New Studies Using its e-Clinical Trial Management Products and Services.Rapid Industry Adoption of Nextrials' Prism[R] Accelerates Company's Growth in Final Months of 2006 SAN RAMON San Ramon (Spanish for "Saint Raymond") may refer to one of the following places:
See: Export Development Corp. ) technology by pharmaceutical, biotechnology and medical device companies is helping Nextrials maintain the forward momentum it established in 2005, resulting in significant enterprise-wide deployments and Prism's selection for use in larger, multi-site clinical trials in 2006. Some of Nextrials' newest customers include ArQule, Inc., MAP Pharmaceuticals, Threshold Pharmaceuticals, Allon Therapeutics Inc. and Quark quark (kwôrk): see elementary particles. quark Any of a group of subatomic particles thought to be among the fundamental constituents of matter—more specifically, of protons and neutrons. Biotech, Inc., conducting studies ranging from a single site Phase I trial to a multi-year study involving a large number of patients at multiple international sites. "In 2005, we began to gain real traction for our electronic data capture system within the biopharmaceutical and device research community," noted James Rogers For the mathematician see Leonard James Rogers. For the United States Representative, see James Rogers (congressman). James Rogers VC (June 2, 1875 - October 28,1961) was an Australian recipient of the Victoria Cross, the highest and most prestigious award for gallantry , co-founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Nextrials. "In 2006, we responded to industry changes by adding support for the CDISC CDISC Clinical Data Interchange Standards Consortium standard and increasing Prism's interoperability with vendors such as Vitalograph[R], Ltd. for providing real-time access to pulmonary function data. This anticipation of customers' needs and requests helps us continue to deliver the service and quality required for broadening the acceptance of e-clinical trial software and services." Rogers added that Prism's usage in multi-national clinical trials also contributed to the company's success in the latter half of 2006. "There can be no doubt that there is an increasing need for products such as Nextrials' Prism," noted Michael H. Elliott, founder and president of Atrium Research. "There is greater pressure than ever before for organizational efficiency within clinical trials, demanded not only by a pharmaceutical company's economic stakeholders Stakeholders All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. and the regulatory agencies governing its R&D efforts, but by the real need for novel treatments to enter the marketplace more quickly." About Nextrials, Inc. Founded by pharmaceutical researchers in 1999, Nextrials Innovates for Life[TM] by offering today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism([R]), its award-winning Electronic Data Capture (EDC) solution, has been used at over 500 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area “Bay Area” redirects here. For other uses, see Bay Area (disambiguation). The San Francisco Bay Area, colloquially known as the Bay Area or The Bay . For more information, visit www.nextrials.com or call 925-355-3000. A podcast by co-founder Anthony J. Costello on innovative technologies for clinical research is also available at http://pharmavoice.com/podcasts. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion